BBWI
$19.25
+$0.62 (3.30%)+3.30%
OpenLoading chart...
IndexN/A
Market Cap3.88B
Enterprise Value8.61B
Income$0.80B
Sales$7.31B
EmployeesN/A
P/E6.23
P/S0.63
P/B-3.61
P/C5.33
EV/EBITDA6.10
EV/SalesN/A
EPS (ttm)3.09
EarningsN/A
Gross Margin43.74%
Oper. Margin15.44%
Profit Margin8.90%
Volume2.10M
Shs Outstand0.20B
Change3.30%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.31B | $7.43B | $7.56B | $7.88B | $6.43B | $5.41B | $13.24B | $12.63B |
| Cost of Revenue | $4.07B | $4.19B | $4.30B | $4.03B | $3.34B | $3.02B | $8.34B | $7.67B |
| Gross Profit | $3.23B | $3.24B | $3.25B | $3.85B | $3.10B | $2.39B | $4.90B | $4.96B |
| Gross Margin | 44.26% | 43.56% | 43.06% | 48.91% | 48.12% | 44.16% | 37.01% | 39.26% |
| Operating Expenses | $1.97B | $1.95B | $1.88B | $1.85B | $1.49B | $1.35B | $3.66B | $3.23B |
| Operating Income | $1.27B | $1.28B | $1.38B | $2.01B | $1.60B | $1.04B | $1.24B | $1.73B |
| Operating Margin | 17.33% | 17.30% | 18.20% | 25.49% | 24.93% | 19.24% | 9.35% | 13.68% |
| Net Income | $798.00M | $878.00M | $800.00M | $1.33B | $844.00M | $-366.00M | $644.00M | $983.00M |
| Net Margin | 10.92% | 11.82% | 10.58% | 16.91% | 13.12% | -6.77% | 4.87% | 7.78% |
| EPS (Basic) | $3.62 | $3.89 | $3.45 | $4.96 | $3.04 | $-1.33 | $2.33 | $3.46 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $4.87B | $5.46B | $5.49B | $6.03B | $11.57B | $10.13B | $8.09B | $8.15B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $6.25B | $7.09B | $7.70B | $7.54B | $12.23B | $11.62B | $8.96B | $8.90B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $-1.39B | $-1.63B | $-2.21B | $-1.52B | $-662.00M | $-1.50B | $-869.00M | $-753.00M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $-1.39B | $-1.63B | $-2.21B | $-1.52B | $-662.00M | $-1.50B | $-869.00M | $-753.00M |
| Total Liabilities & Stockholders Equity | $4.87B | $5.46B | $5.49B | $6.03B | $11.57B | $10.13B | $8.09B | $8.15B |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $798.00M | $878.00M | $800.00M | $1.33B | $844.00M | $-366.00M | $644.00M | $983.00M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $886.00M | $954.00M | $1.14B | $1.49B | $2.04B | $1.24B | $1.38B | $1.41B |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
Bath & Body Works Introduces ‘Fruit Fusion’ Franchise with Hilary Duff as Campaign Ambassador and Creative PartnerGlobeNewswire Inc. Dow Jones Hit Records Above 50,600 As Oil Sinks Below $90: Stock Market TodayBenzinga Bath & Body Works Declares Cash DividendBenzinga Bath & Body Works launches an out-of-this-galaxy collection to celebrate the release of Star Wars: The Mandalorian and Grogu, only in theaters May 22GlobeNewswire Inc. $1,000 and a Rocky Market: These 6 Cheap Stocks Are Exactly Where I'd StartThe Motley Fool Stocks Rise As Powell's Remarks Cool Rate Fears: What's Moving Markets Monday?Benzinga BBWI FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Bath & Body Works, Inc. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action - BBWIGlobeNewswire Inc. BBWI DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Bath & Body Works, Inc. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action - BBWIGlobeNewswire Inc.
Show 12 more stories
Bronstein, Gewirtz & Grossman LLC Urges Bath & Body Works, Inc. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire Inc. Deadline Alert: Bath & Body Works, Inc. (BBWI) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlobeNewswire Inc. Bronstein, Gewirtz & Grossman LLC Urges Bath & Body Works, Inc. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire Inc. BBWI IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bath & Body Works, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 16 Deadline in Securities Class Action - BBWIGlobeNewswire Inc. The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 13, 2026 in Bath & Body Works, Inc. Lawsuit – BBWIGlobeNewswire Inc. Bragar Eagel & Squire, P.C. Urges Bath & Body Works, Inc. (NYSE: BBWI) Stockholders with Significant Losses to Contact the FirmGlobeNewswire Inc. DEADLINE ALERT for VRNS, ARDT, CRWV, BBWI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class ActionsGlobeNewswire Inc. Robbins LLP Reminds BBWI Stockholders of the March 16, 2026 Lead Plaintiff Deadline – Contact the Firm Today for Information About Leading the Bath & Body Works, Inc. Class ActionGlobeNewswire Inc. SDM IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Smart Digital Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SDMGlobeNewswire Inc. BBWI FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Bath & Body Works, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBWIGlobeNewswire Inc. Bath & Body Works Hops Into Spring With Joy-Filled PEEPS® CollaborationGlobeNewswire Inc. Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against CoreWeave, Inc. (CRWV), Bath & Body Works, Inc. (BBWI), and Vistagen Therapeutics, Inc. (VTGN) Announced by Holzer & Holzer, LLCGlobeNewswire Inc.
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
Discover more
You may be interested in